Latest filing published 05 Apr 2017 for NEVRO CORP, €5,056.
Filing timeline
BuySaleInsider track record
Michael Enxing: trading record in brief
All filings by Michael Enxing on record concern Nevro Corp. We count 45 filings; the first trade dates from 3 March 2016 and the latest from 4 April 2017.
The open-market record consists of 29 sales worth €5.0M, with no purchase. Besides market trades, the filings include 1 share grant and 15 option exercises. So far in 2017, the count stands at no purchases and 10 sales.
On 5 April 2017 came the latest disclosure, an open-market sale for €27k in Nevro Corp. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael Enxing
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,500 shares@ US$3.600.1% of flowCommon StockSEC:0001140361-17-014936:0
- 1,200 shares@ US$93.292.0% of flowCommon StockSEC:0001140361-17-014936:1
- 300 shares@ US$94.480.5% of flowCommon StockSEC:0001140361-17-014936:2
- 37,000 shares@ US$90.9959.2% of flowCommon StockSEC:0001140361-17-010973:0
- 1,500 shares@ US$3.600.1% of flowCommon StockSEC:0001140361-17-010973:1
- 800 shares@ US$90.901.3% of flowCommon StockSEC:0001140361-17-010973:2
- 600 shares@ US$92.351.0% of flowCommon StockSEC:0001140361-17-010973:3
- 100 shares@ US$92.850.2% of flowCommon StockSEC:0001140361-17-010973:4
- 1,500 shares@ US$3.600.1% of flowCommon StockSEC:0001140361-17-005058:0
- 1,500 shares@ US$93.272.4% of flowCommon StockSEC:0001140361-17-005058:1
- 37,000 shares@ US$3.602.3% of flowCommon StockSEC:0001140361-17-003373:0
- 1,500 shares@ US$3.600.1% of flowCommon StockSEC:0001140361-17-000832:0
- 600 shares@ US$74.960.8% of flowCommon StockSEC:0001140361-17-000832:1
- 500 shares@ US$76.120.7% of flowCommon StockSEC:0001140361-17-000832:2
- 400 shares@ US$76.970.6% of flowCommon StockSEC:0001140361-17-000832:3
- 1,500 shares@ US$3.600.1% of flowCommon StockSEC:0001140361-16-088966:0
- 1,500 shares@ US$76.382.0% of flowCommon StockSEC:0001140361-16-088966:1
- 2,500 shares0Common StockSEC:0001140361-16-087304:0
- 1,500 shares@ US$3.600.1% of flowCommon StockSEC:0001140361-16-085357:0
- 266 shares@ US$83.750.4% of flowCommon StockSEC:0001140361-16-085357:1
- 365 shares@ US$85.340.5% of flowCommon StockSEC:0001140361-16-085357:2
- 300 shares@ US$86.290.4% of flowCommon StockSEC:0001140361-16-085357:3
- 550 shares@ US$87.930.8% of flowCommon StockSEC:0001140361-16-085357:4
- 19 shares@ US$88.680.0% of flowCommon StockSEC:0001140361-16-085357:5
- 1,500 shares@ US$3.600.1% of flowCommon StockSEC:0001140361-16-082133:0
25 of 45 declarations
